India's s very first government-authorised trials for stem cell-based therapies will commence next month in hospitals countrywide.
In a bid to bring affordable, off-the-shelf stem cell products to the Indian market, Bangalore-based biotechnology firm Stempeutics Research will start multi-centre, stem cell-based clinical trials on patients with diabetes, liver cirrhosis, osteoarthritis and chronic